We have updated our Privacy Policy. Please review our Privacy Policy. This website uses cookies. By using our website without changing your cookie settings, you agree to our use of cookies as described in our Privacy Policy.

Close
VIVITROL is a prescription injectable medicine used to:
  • Treat alcohol dependence. You should stop drinking before starting VIVITROL.
  • Prevent relapse to opioid dependence, after opioid detoxification.

You must stop taking opioids before you start receiving VIVITROL. To be effective, VIVITROL must be used with other alcohol or drug recovery programs such as counseling.

VIVITROL may not work for everyone. It is not known if VIVITROL is safe and effective in children.

If you're considering VIVITROL® as part of your recovery journey, know that along with counseling, VIVITROL has been prescribed for alcohol dependence since 2006.1

What has VIVITROL shown
in clinical trials?

Learn more

What is the dosing
of VIVITROL?

Find out now

Ready to start a conversation
with your doctor?

Learn more

Everyone's recovery journey is different. Talk to your healthcare provider to see if VIVITROL is right for you.

VIVITROL is not right for everyone. There are significant risks from VIVITROL treatment, including risk of opioid overdose, severe reactions at the injection site, sudden opioid withdrawal, liver damage or hepatitis.

Talk to your healthcare provider about naloxone, a medicine that is available to patients for the emergency treatment of an opioid overdose.

Call 911 or get emergency medical help right away in all cases of known or suspected opioid overdose, even if naloxone is administered.

If you are being treated for alcohol dependence but also use or are addicted to opioid-containing medicines or opioid street drugs, it is important that you tell your healthcare provider before starting VIVITROL to avoid having sudden opioid withdrawal symptoms when you start VIVITROL treatment.

See Important Safety Information.

See Prescribing Information and Medication Guide.


Reference: 1. Extended-release injectable naltrexone. In: Incorporating Alcohol Pharmacotherapies Into Medical Practice. Treatment Improvement Protocol (TIP) Series, No. 49. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2009. Accessed August 11, 2023. https://www.ncbi.nlm.nih.gov/books/NBK64031/

Reference: 1. Extended-release injectable naltrexone. In: Incorporating Alcohol Pharmacotherapies Into Medical Practice. Treatment Improvement Protocol (TIP) Series, No. 49. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2009. Accessed August 11, 2023. https://www.ncbi.nlm.nih.gov/books/NBK64031/

We have updated our Privacy Policy. Please review our Privacy Policy. This website uses cookies. By using our website without changing your cookie settings, you agree to our use of cookies as described in our Privacy Policy.

Close